{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T03:22:32Z","timestamp":1795058552933,"version":"4.10.2"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"DOI":"10.1186\/s12865-026-00814-y","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T07:55:27Z","timestamp":1771401327000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["IL-23 serum levels and IL23R polymorphisms in psoriasis: a meta-analysis of susceptibility and severity"],"prefix":"10.1186","volume":"27","author":[{"given":"Saboor","family":"Ahmadipanah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parand","family":"Shariat Rad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Montaseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houshang","family":"Nemati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazaher","family":"Ramezani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"814_CR1","doi-asserted-by":"publisher","unstructured":"Almenara-Blasco M, et al. Multimorbidity of psoriasis: A Large-Scale population study of its associated comorbidities. J Clin Med. 2024;13. https:\/\/doi.org\/10.3390\/jcm13020492.","DOI":"10.3390\/jcm13020492"},{"issue":"5","key":"814_CR2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.adengl.2019.01.014","volume":"110","author":"JM Fern\u00e1ndez-Armenteros","year":"2019","unstructured":"Fern\u00e1ndez-Armenteros JM, et al. Epidemiology of Psoriasis. A Population-Based study. Actas Dermo-Sifiliogr\u00e1ficas (English Edition). 2019;110(5):385\u201392.","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas (English Edition)"},{"issue":"1","key":"814_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s13671-012-0034-6","volume":"2","author":"L Naldi","year":"2013","unstructured":"Naldi L. Risk factors for psoriasis. Curr Dermatology Rep. 2013;2(1):58\u201365.","journal-title":"Curr Dermatology Rep"},{"issue":"2","key":"814_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jdin.2020.06.002","volume":"1","author":"MHM El-Komy","year":"2020","unstructured":"El-Komy MHM, et al. Clinical and epidemiologic features of psoriasis patients in an Egyptian medical center. JAAD Int. 2020;1(2):81\u201390.","journal-title":"JAAD Int"},{"issue":"1","key":"814_CR5","first-page":"79","volume":"3","author":"G Sarac","year":"2016","unstructured":"Sarac G, Koca TT, Baglan T. A brief summary of clinical types of psoriasis. North Clin Istanb. 2016;3(1):79\u201382.","journal-title":"North Clin Istanb"},{"key":"814_CR6","doi-asserted-by":"publisher","first-page":"649408","DOI":"10.3389\/fmed.2021.649408","volume":"8","author":"BX Yan","year":"2021","unstructured":"Yan BX, et al. Cutaneous and systemic psoriasis: classifications and classification for the distinction. Front Med (Lausanne). 2021;8:649408.","journal-title":"Front Med (Lausanne)"},{"key":"814_CR7","doi-asserted-by":"crossref","unstructured":"Bugaut H, Aractingi S. Major role of the IL17\/23 axis in psoriasis supports the development of new targeted therapies. Frontiers in Immunology; 2021. pp. 12\u20132021.","DOI":"10.3389\/fimmu.2021.621956"},{"issue":"3","key":"814_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1346-8138.2011.01458.x","volume":"39","author":"K Nakajima","year":"2012","unstructured":"Nakajima K. Critical role of the interleukin-23\/\/T-helper 17 cell axis in the pathogenesis of psoriasis. J Dermatol. 2012;39(3):219\u201324.","journal-title":"J Dermatol"},{"key":"814_CR9","doi-asserted-by":"publisher","first-page":"829","DOI":"10.2147\/CCID.S462797","volume":"17","author":"L Potestio","year":"2024","unstructured":"Potestio L, et al. The role of Interleukin 23\/17 axis in psoriasis management: A comprehensive review of clinical trials. Clin Cosmet Investig Dermatol. 2024;17:829\u201342.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"9","key":"814_CR10","doi-asserted-by":"publisher","first-page":"e15180","DOI":"10.1111\/exd.15180","volume":"33","author":"SS Rane","year":"2024","unstructured":"Rane SS, et al. IL23R mutations associated with decreased risk of psoriasis lead to the differential expression of genes implicated in the disease. Exp Dermatol. 2024;33(9):e15180.","journal-title":"Exp Dermatol"},{"issue":"1","key":"814_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3899\/jrheum.080458","volume":"36","author":"P Rahman","year":"2009","unstructured":"Rahman P, et al. Association of Interleukin 23 receptor variants with psoriatic arthritis. J Rheumatol. 2009;36(1):137\u201340.","journal-title":"J Rheumatol"},{"issue":"2","key":"814_CR12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/jid.2008.233","volume":"129","author":"U H\u00fcffmeier","year":"2009","unstructured":"H\u00fcffmeier U, et al. Genetic variants of the IL-23R pathway: association with psoriatic arthritis and psoriasis Vulgaris, but no specific risk factor for arthritis. J Invest Dermatology. 2009;129(2):355\u20138.","journal-title":"J Invest Dermatology"},{"issue":"5","key":"814_CR13","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.3906\/sag-1904-48","volume":"49","author":"B Filiz","year":"2019","unstructured":"Filiz B, et al. Evaluation of interleukin-23 receptor (IL-23R) gene polymorphisms and serum IL-23 levels in patients with psoriasis. Turk J Med Sci. 2019;49(5):1386\u201394.","journal-title":"Turk J Med Sci"},{"issue":"7","key":"814_CR14","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1038\/sj.jid.5701255","volume":"128","author":"RP Nair","year":"2008","unstructured":"Nair RP, et al. Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. J Invest Dermatol. 2008;128(7):1653\u201361.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"814_CR15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/jid.2008.233","volume":"129","author":"U H\u00fcffmeier","year":"2009","unstructured":"H\u00fcffmeier U, et al. Genetic variants of the IL-23R pathway: association with psoriatic arthritis and psoriasis vulgaris, but no specific risk factor for arthritis. J Invest Dermatol. 2009;129(2):355\u20138.","journal-title":"J Invest Dermatol"},{"key":"814_CR16","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"7109","key":"814_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"},{"key":"814_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.cyto.2016.06.020","volume":"85","author":"MJ Brito-Luna","year":"2016","unstructured":"Brito-Luna MJ, et al. Correlation of IL-12, IL-22, and IL-23 in patients with psoriasis and metabolic syndrome. Preliminary report. Cytokine. 2016;85:130\u20136.","journal-title":"Cytokine"},{"issue":"6","key":"814_CR19","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1155\/2013\/856056","volume":"35","author":"A Michalak-Stoma","year":"2013","unstructured":"Michalak-Stoma A, et al. Serum levels of selected Th17 and Th22 cytokines in psoriatic patients. Dis Markers. 2013;35(6):625\u201331.","journal-title":"Dis Markers"},{"issue":"6","key":"814_CR20","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1177\/1203475415584503","volume":"19","author":"C Fotiadou","year":"2015","unstructured":"Fotiadou C, et al. IL-17A, IL-22, and IL-23 as markers of psoriasis activity: A Cross-sectional, Hospital-based study. J Cutan Med Surg. 2015;19(6):555\u201360.","journal-title":"J Cutan Med Surg"},{"key":"814_CR21","doi-asserted-by":"publisher","first-page":"467541","DOI":"10.1155\/2014\/467541","volume":"2014","author":"A Kyriakou","year":"2014","unstructured":"Kyriakou A, et al. Serum levels of TNF-\u03b1, IL-12\/23p40, and IL-17 in plaque psoriasis and their correlation with disease severity. J Immunol Res. 2014;2014:467541.","journal-title":"J Immunol Res"},{"issue":"7","key":"814_CR22","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/ced.12845","volume":"41","author":"S Chhabra","year":"2016","unstructured":"Chhabra S, et al. Circulating T-helper 17 cells and associated cytokines in psoriasis. Clin Exp Dermatol. 2016;41(7):806\u201310.","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"814_CR23","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10753-010-9268-2","volume":"34","author":"E Safrany","year":"2011","unstructured":"Safrany E, et al. Polymorphisms of the IL23R gene are associated with psoriasis but not with Immunoglobulin A nephropathy in a Hungarian population. Inflammation. 2011;34(6):603\u20138.","journal-title":"Inflammation"},{"issue":"3","key":"814_CR24","doi-asserted-by":"publisher","first-page":"e1000041","DOI":"10.1371\/journal.pgen.1000041","volume":"4","author":"Y Liu","year":"2008","unstructured":"Liu Y, et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet. 2008;4(3):e1000041.","journal-title":"PLoS Genet"},{"issue":"12","key":"814_CR25","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.humimm.2010.09.014","volume":"71","author":"Y Wu","year":"2010","unstructured":"Wu Y, et al. Replication of association between interleukin-23 receptor (IL-23R) and its ligand (IL-12B) polymorphisms and psoriasis in the Chinese Han population. Hum Immunol. 2010;71(12):1255\u20138.","journal-title":"Hum Immunol"},{"issue":"9","key":"814_CR26","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1111\/j.1468-3083.2012.04683.x","volume":"27","author":"WJ Wang","year":"2013","unstructured":"Wang WJ, et al. Gene-gene interactions in IL23\/Th17 pathway contribute to psoriasis susceptibility in Chinese Han population. J Eur Acad Dermatol Venereol. 2013;27(9):1156\u201362.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"814_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00011-012-0566-z","volume":"62","author":"E Safrany","year":"2013","unstructured":"Safrany E, et al. Difference of interleukin-23 receptor gene haplotype variants in ulcerative colitis compared to crohn\u2019s disease and psoriasis. Inflamm Res. 2013;62(2):195\u2013200.","journal-title":"Inflamm Res"},{"issue":"5","key":"814_CR28","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1038\/sj.jid.5701140","volume":"128","author":"RL Smith","year":"2008","unstructured":"Smith RL, et al. Polymorphisms in the IL-12beta and IL-23R genes are associated with psoriasis of early onset in a UK cohort. J Invest Dermatol. 2008;128(5):1325\u20137.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"814_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jdermsci.2014.05.010","volume":"75","author":"N Eir\u00eds","year":"2014","unstructured":"Eir\u00eds N, et al. Genetic variation at IL12B, IL23R and IL23A is associated with psoriasis severity, psoriatic arthritis and type 2 diabetes mellitus. J Dermatol Sci. 2014;75(3):167\u201372.","journal-title":"J Dermatol Sci"},{"issue":"12","key":"814_CR30","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1002\/art.24128","volume":"58","author":"C Filer","year":"2008","unstructured":"Filer C, et al. Investigation of association of the IL12B and IL23R genes with psoriatic arthritis. Arthritis Rheum. 2008;58(12):3705\u20139.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"814_CR31","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1684\/ejd.2013.2144","volume":"23","author":"T Cabaleiro","year":"2013","unstructured":"Cabaleiro T, et al. Association between psoriasis and polymorphisms in the TNF, IL12B, and IL23R genes in Spanish patients. Eur J Dermatol. 2013;23(5):640\u20135.","journal-title":"Eur J Dermatol"},{"issue":"4","key":"814_CR32","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.humimm.2018.02.003","volume":"79","author":"A Bojko","year":"2018","unstructured":"Bojko A, et al. IL12B, IL23A, IL23R and HLA-C*06 genetic variants in psoriasis susceptibility and response to treatment. Hum Immunol. 2018;79(4):213\u20137.","journal-title":"Hum Immunol"},{"issue":"2","key":"814_CR33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00439-007-0397-0","volume":"122","author":"F Capon","year":"2007","unstructured":"Capon F, et al. Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum Genet. 2007;122(2):201\u20136.","journal-title":"Hum Genet"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-026-00814-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-026-00814-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-026-00814-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T09:53:34Z","timestamp":1774518814000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12865-026-00814-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["814"],"URL":"https:\/\/doi.org\/10.1186\/s12865-026-00814-y","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}